MISC

1996年7月

Lymphatic transport of cholesterol in normocholesterolemic rats treated with pravastatin, an inhibitor of HMG-CoA reductase

Atherosclerosis
  • Masanobu Sakono
  • ,
  • Toko Ibi
  • ,
  • Koji Nagao
  • ,
  • Ikuo Ikeda
  • ,
  • Kyosuke Yamamoto
  • ,
  • Katsumi Imaizumi

124
1
開始ページ
95
終了ページ
102
記述言語
英語
掲載種別
DOI
10.1016/0021-9150(96)05826-1
出版者・発行元
ELSEVIER SCI IRELAND LTD

Lymphatic absorption and transport of cholesterol and triacylglycerols were examined in rats treated with pravastatin, an inhibitor of 3-hydroxy-3-methyglutaryl-CoA (HMG-CoA) reductase. Pravastatin-treatment for 1, 7 and 28 days did not affect the recovery of cholesterol and triacylglycerols during 24 h after the lipid administration: the recovery was 52-59% and 82-93% for cholesterol and triacylglycerols, respectively. Rats treated with pravastatin for 28 days had a higher lymphatic recovery of the lipids during 3-6 h after the lipid administration than did control rats. Pravastatin treatment did not affect the ratio of phospholipid to cholesterol in the gut mucosa, the fatty acid composition of the lymph and mucosal lipids. We concluded that an inhibitor of HMG-CoA reductase would exert no adverse effect on absorption of fat-soluble nutrients by gut.

リンク情報
DOI
https://doi.org/10.1016/0021-9150(96)05826-1
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/8800497
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:A1996UU49500009&DestApp=WOS_CPL
Scopus
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0029951396&origin=inward
Scopus Citedby
https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=0029951396&origin=inward
ID情報
  • DOI : 10.1016/0021-9150(96)05826-1
  • ISSN : 0021-9150
  • PubMed ID : 8800497
  • SCOPUS ID : 0029951396
  • Web of Science ID : WOS:A1996UU49500009

エクスポート
BibTeX RIS